GACM
EPZM

Green Arrow Capital Management’s Epizyme, Inc EPZM Stock Holding History

Green Arrow Capital Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-30,000
Closed -$934K – 218
2014
Q2 		$934K Buy
+30,000
New +$706K 0.12% 139

Other funds holding EPZM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Green Arrow Capital Management's EPZM Position: Q3 2014 in Review

Green Arrow Capital Management sold out of Epizyme, Inc (EPZM) in Q3 2014, closing a stake of 30,000 shares — an estimated $934K sold.

Green Arrow Capital Management first reported a position in EPZM in Q2 2014 and held it in 1 quarter. The position peaked at $934K in Q2 2014. 94 funds tracked by Wall St. Rank hold EPZM as of Q3 2014.

  • Green Arrow Capital Management reported no remaining Epizyme, Inc position as of Q3 2014 after selling out during the quarter.
  • Green Arrow Capital Management sold 30,000 Epizyme, Inc shares in Q3 2014, an estimated $934K.
  • Green Arrow Capital Management first reported a position in Epizyme, Inc in Q2 2014 and held it in 1 quarter.
  • Green Arrow Capital Management's Epizyme, Inc position peaked at $934K in Q2 2014.
  • 94 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2014.

Based on Green Arrow Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.